<Disease><Name>HYPERGLYCINURIA</Name><Synonym>AMINOGLYCINURIA TYPE 2</Synonym><OMIM><Number>138500</Number><URL>http://omim.org/entry/138500</URL></OMIM><Orphanet><Number>62062</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=62062</URL></Orphanet><Protein><Number>Proton-coupled amino acid transporter 2</Number><URL>https://www.uniprot.org/uniprot/?query=database:(type:mim%20138500)&amp;sort=score</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>5q33.1</Gene><ICD /><Summary>rare;autosomal dominant;mutation in the SLC36A2 gene</Summary><Symptoms><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1621</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>44.00</min><max>300.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1766</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>87.00</min><max>1900.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1944</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>122.00</min><max>550.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1945</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>166.00</min><max>330.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1946</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>130.00</min><max>400.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>36</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>210.00</min><max>743.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>830</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>110.00</min><max>356.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>862</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>283.00</min><max>1097.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1414</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>180.00</min><max>1633.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>1-7d</comment></metabolite><metabolite><id>1909</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>64.00</min><max>236.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1910</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>43.00</min><max>173.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>35</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>230.00</min><max>500.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>474</id><name>Glycine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>1.90</min><max>10.00</max><unit>&#956;mol/l</unit><age>3m-10years</age><method /><comment /></metabolite><metabolite><id>977</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>100.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>738</id><name>Glycine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.02</min><max>0.04</max><unit>ratio</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1272</id><name>Glycine</name><specimen>blood</specimen><value>increased</value><min>85.10</min><max>536.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1273</id><name>Glycine</name><specimen>serum</specimen><value>increased</value><min>144.67</min><max>911.20</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>3808</id><title>Diseases associated with general amino acid transporters of the solute carrier 6 family (SLC6)</title><author>Broer S</author><journal>Curr Mol Pharmacol</journal><year>2013</year><book /><volume>6</volume><number>2</number><pages>74-87</pages><co_aut /></literature><literature><id>7603</id><title>Amino acid derivatives are substrates or non-transported inhibitors of the amino acid transporter PAT2 (slc36a2)</title><author>Edwards N,</author><journal>Biochim Biophys Acta</journal><year>2011</year><book /><volume>1808</volume><number>1</number><pages>260-270</pages><co_aut>et al.</co_aut></literature><literature><id>3810</id><title>Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters</title><author>Broer S,</author><journal>J Clin Invest</journal><year>2008</year><book /><volume>118</volume><number>12</number><pages>3881-3892</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>